Haematology · Internal Medicine
VTE-BLEED Score calculator
Enter the published formula inputs below to calculate and interpret this score.
Clinical inputs
Result
Anyone can run this calculator. Sign in to save, favourite, or send the result.
0
Low risk (<2 points)
Band: Low risk (<2 points)
Interpretation. Low risk (<2 points)
Suggested management. Interpret only within the cited source population and criteria; use alongside complete clinical assessment.
VTE-BLEED Score: 0 — Low risk (<2 points). Interpretation: Low risk (<2 points) What to do: Interpret only within the cited source population and criteria; use alongside complete clinical assessment. Inputs: Active cancer (+2): false; Male with uncontrolled hypertension (SBP ≥140 mmHg) (+1): false; Anemia (+1.5): false; History of bleeding (+1.5): false; Age ≥60 years (+1.5): false; Renal dysfunction (CrCl/eGFR 30–60 mL/min) (+1.5): false Source: Klok FA et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J. DOI: 10.1183/13993003.00280-2016. PMID: 27471209. Scope: VTE-BLEED score (max 9 points): active cancer (2), male with uncontrolled arterial hypertension — SBP ≥140 mmHg (1), anemia — Hb <13 g/dL men / <12 g/dL women (1.5), history of bleeding (1.5), age ≥60 years (1.5), and renal dysfunction — CrCl/eGFR 30–60 mL/min (1.5). Score <2 = low bleeding risk; ≥2 = high bleeding risk. (2016)
Ruqelo is AI and can make mistakes. Check important information.
Clinical inputs
- Active cancer (+2)
- Male with uncontrolled hypertension (SBP ≥140 mmHg) (+1)
- Anemia (+1.5)
- History of bleeding (+1.5)
- Age ≥60 years (+1.5)
- Renal dysfunction (CrCl/eGFR 30–60 mL/min) (+1.5)
Primary source
Klok FA et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J. DOI: 10.1183/13993003.00280-2016. PMID: 27471209. Scope: VTE-BLEED score (max 9 points): active cancer (2), male with uncontrolled arterial hypertension — SBP ≥140 mmHg (1), anemia — Hb <13 g/dL men / <12 g/dL women (1.5), history of bleeding (1.5), age ≥60 years (1.5), and renal dysfunction — CrCl/eGFR 30–60 mL/min (1.5). Score <2 = low bleeding risk; ≥2 = high bleeding risk. (2016)
View source